Evidence map›Paper›PMID 35847323›Full record

ArticleACS omega2022

Photoactivation of Chemotherapeutic Agents with Cerenkov Radiation for Chemo-Photodynamic Therapy.

Uriel Gallaga-González, Enrique Morales-Avila, Eugenio Torres-García, José A Estrada, Luis Enrique Díaz-Sánchez, German Izquierdo, Liliana Aranda-Lara, Keila Isaac-Olivé

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Uriel Gallaga-GonzálezLaboratorio de Investigación Teranóstica. Facultad de Medicina, Universidad Autónoma del Estado de México, Toluca, 50180 Estado de México, México.
Enrique Morales-AvilaLaboratorio de Toxicología y Farmacia, Facultad de Química, Universidad Autónoma del Estado de México, Toluca, 50120 Estado de México, México.
Eugenio Torres-GarcíaLaboratorio de Dosimetría y Simulación Monte Carlo, Facultad de Medicina, Universidad Autónoma del Estado de México, Toluca, 50180 Estado de México, México.
José A EstradaLaboratorio de Neuroquímica, Facultad de Medicina, Universidad Autónoma del Estado de México, Toluca, 50180 Estado de México, México.
Luis Enrique Díaz-SánchezFacultad de Ciencias, Universidad Autónoma del Estado de México, Toluca, 50120 Estado de México, México.
German IzquierdoFacultad de Ciencias, Universidad Autónoma del Estado de México, Toluca, 50120 Estado de México, México.
Liliana Aranda-LaraLaboratorio de Investigación Teranóstica. Facultad de Medicina, Universidad Autónoma del Estado de México, Toluca, 50180 Estado de México, México.
Keila Isaac-OlivéLaboratorio de Investigación Teranóstica. Facultad de Medicina, Universidad Autónoma del Estado de México, Toluca, 50180 Estado de México, México.ORCID https://orcid.org/0000-0003-4388-3811
Universidad Autónoma del Estado de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerenkov radiation (CR) can be used as an internal light source in photodynamic therapy (PDT). Methotrexate (MTX) and paclitaxel (PTX), chemotherapeutic agents with wide clinical use, have characteristics of photosensitizers (PS). This work evaluates the possibility of photoexciting MTX and PTX with CR from

Identifiers

PMID35847323
PMCPMC9280781
OpenAlexW4283759186

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.